A Phase II Study to examine the efficacy and safety of a new drug called Sevuparin on resolution of painful vaso-occlusive crisis in patients with sickle-cell disease.
2020-07-04
عنوان الدراسة
A Phase II Study to examine the efficacy and safety of a new drug called Sevuparin on resolution of painful vaso-occlusive crisis in patients with sickle-cell disease.
داعم الدراسة
Dilaforette AB
دواء الدراسة
Sevuparin
رقم بروتوكول الدراسة
TVOC01
حالة الدراسة
Ongoing
موقع الدراسة
King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh), Qatif Central Hospital
مرحلة الدراسة
2
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.